Skip to main content

Roles of Sustainable Biomaterials in Biomedical Engineering for Ischemic Stroke Therapy

  • Chapter
  • First Online:
Sustainable Material for Biomedical Engineering Application

Abstracts

Ischemic stroke is the leading cause of adult disability which imposes high socio-economic burden worldwide. Natural and synthetic biomaterials have been elucidated as viable strategies for the treatment of ischemic stroke since decades. Nowadays, due to the advanced development in biomedical engineering, biomaterial applications have been perfected for sustainable usage in different phases of in vitro, in vivo and clinical studies. This chapter reviews a broad range of sustainable biomaterials and major therapeutic roles of sustainable biomaterials for ischemic stroke treatment. Furthermore, the neurological recovery effects triggered by these engineered biomaterials after being implanted into in vivo ischemic stroke models are highlighted as well. In brief, this chapter presents the roles and potentials of sustainable biomaterials in biomedical engineering for ischemic stroke therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

ASP:

Spermine-modified amylose

ATP:

Adenosine triphosphate

BBB:

Blood brain barrier

BCSFB:

Blood-cerebrospinal-fluid barrier

bFGF:

Basic fibroblast growth factor

CAM:

Cell adhesion molecule

CDI:

1,1′-carbonyldiimidazole

CNS:

Central nervous system

CS-maleimide:

Chitosan-maleimide

ECM:

Extracellular matrix

ECs:

Endothelial cells

FDA:

Food and Drug Administration

Fuco-SPs:

Fucoidan-functionalized dextran submicroparticles

GFP:

Green fluorescent protein

HA:

Hyaluronic acid

HUVECs:

Human umbilical vein endothelial cells

I/R:

Ischemia/reperfusion

IV:

Intravenous

LBD:

Laminin-binding domain

MC:

Methylcellulose

MCA:

Middle cerebral artery

MCAO:

Middle cerebral artery occlusion

MRI:

Magnetic resonance imaging

MSCs:

Mesenchymal stem cells

Ngn2:

Neurogenin-2

NSCs:

Neural stem cells

OD:

Optical density

OGD:

Oxygen glucose deprivation

PA:

Palmitic acid

PCNs:

Polyelectrolyte complex nanoparticles

PEG:

Polyethylene glycol

pH:

Potential hydrogen

PLA:

Poly lactic acid

PLGA:

Poly (lactic-co-glycolic acid)

PTD:

Protein transduction domain

ROS:

Reactive oxygen species

rtPA:

Recombinant tissue plasminogen activator

RUI:

Research University Individual

SDF-1α:

Stromal derived factor 1α

SPION:

Superparamagnetic iron oxide nanoparticles

SVZ:

Subventricular zone

TAT:

Transactivator of transcription

References

Download references

Acknowledgement

This work was supported by Universiti Sains Malaysia (USM) Research University Individual (RUI) Grant, No: 1001/PPSK/8012273. All authors thank the Universiti Sains Malaysia libraries, particularly Perpustakaan Hamdan Tahir and Perpustakaan Hamzah Sendut, for providing the resources to write this book chapter. The authors also appreciate all the scientists whose previous work contributed to this review article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Suat Cheng Tan .

Editor information

Editors and Affiliations

Ethics declarations

All authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Othman, F.A., Satar, A.M., Tan, S.C. (2023). Roles of Sustainable Biomaterials in Biomedical Engineering for Ischemic Stroke Therapy. In: Wan Kamarul Zaman, W.S., Abdullah, N.a. (eds) Sustainable Material for Biomedical Engineering Application. Springer, Singapore. https://doi.org/10.1007/978-981-99-2267-3_19

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-2267-3_19

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-2266-6

  • Online ISBN: 978-981-99-2267-3

  • eBook Packages: EngineeringEngineering (R0)

Publish with us

Policies and ethics